Horizon Therapeutics

Horizon Therapeutics is a biopharmaceutical company focused on developing prescription medications for mild to moderate pain relief and arthritis. The company's product candidates include HZT-501, a proprietary fixed-dose combination formulation of an NSAID and ibuprofen, and HZT-602, an oral drug combination consisting of naproxen and famotidine. Horizon’s drug portfolio is primarily used for the treatment of arthritis, pain, and inflammatory diseases.